Post-Transplant Complement-Binding Donor-Specific Anti-HLA Antibodies Are Strong Predictors of Kidney Allograft Outcome

被引：0
|
作者：
Lefaucheur, C. [1 ]
Loupy, A. [2 ]
Suberbielle, C. [3 ]
Charron, D. [3 ]
Legendre, C. [2 ]
Glotz, D. [1 ]
Zeevi, A. [4 ]
机构：
[1] St Louis Hosp, Nephrol & Kidney Transplantat, Paris, France
[2] Hop Necker Enfants Malad, Nephrol & Kidney Transplantat, Paris, France
[3] St Louis Hosp, Histocompatibil, Paris, France
[4] Univ Pittsburgh, Pittsburgh, PA USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00118
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
900
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [21] COMPLEMENT- AND NON-COMPLEMENT-BINDING DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES AND KIDNEY ALLOGRAFT SURVIVAL
    Guerville, Florent
    Guidicelli, Gwendaline
    Lepreux, Sebastien
    Wiebe, Chris
    Thaunat, Olivier
    Dubois, Valerie
    Visentin, Jonathan
    Bachelet, Thomas
    Morelon, Emmanuel
    Nickerson, Peter
    Merville, Pierre
    Taupin, Jean-Luc
    Couzi, Lionel
    TRANSPLANT INTERNATIONAL, 2015, 28 : 119 - 119
  • [22] CLINICAL SIGNIFICANCE OF COMPLEMENT-BINDING DONOR-SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Rodova, Marketa
    Fornbaumova, Iva
    Janatova, Katerina
    Sekerkova, Zuzana
    Slavcev, Antonij
    HLA, 2017, 89 (06) : 404 - 405
  • [23] Impairment of renal allograft function by post-transplant anti-HLA antibodies
    Hou, J.
    TISSUE ANTIGENS, 2008, 72 (03): : 259 - 259
  • [24] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [25] DE NOVO PRODUCTION OF ANTI-HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY ALLOGRAFT RECIPIENTS: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Caputo, Daniela
    Catalano, Manuela
    Imbroglini, Valentina
    Cremona, Rosanna
    Adorno, Domenico
    TRANSPLANT INTERNATIONAL, 2009, 22 : 132 - 132
  • [26] Extended HLA Typing of Kidney Transplant Pairs is Necessary to Assign Presence of Donor-Specific Anti-HLA Antibodies
    Senev, A.
    Van Sandt, V.
    Naesens, M.
    Emonds, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 705 - 706
  • [27] Clinical implication of non-complement-binding de novo donor-specific anti-HLA antibodies in heart transplant recipients
    Sato, Takuma
    Seguchi, Osamu
    Nakajima, Seiko
    Matsuda, Sachi
    Kanaumi, Yoshiaki
    Wada, Kyoichi
    Yanase, Masanobu
    Ueda, Hatsue
    Fukushima, Norihide
    Nakatani, Takeshi
    TRANSPLANTATION, 2016, 100 (07) : S825 - S825
  • [28] CHARACTERISTICS OF PRE-TRANSPLANT DONOR-SPECIFIC ANTI-HLA ANTIBODIES AND OUTCOME IN KIDNEY TRANSPLANT PATIENTS TREATED WITH A STANDARDIZED INDUCTION REGIMEN
    Zecher, D.
    Bach, C.
    Staudner, C.
    Banas, B.
    Spriewald, B.
    Boeger, C.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 34 - 34
  • [29] Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure
    Campos, E. F.
    Tedesco-Silva, H.
    Machado, P. G.
    Franco, M.
    Medina-Pestana, J. O.
    Gerbase-DeLima, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) : 2316 - 2320
  • [30] Luminex screening for donor-specific anti-HLA antibodies in pancreas transplant alone
    Focosi, D.
    De Donno, M.
    Occhipinti, M.
    Marchetti, P.
    Vistoli, F.
    Duquesnoy, R.
    Curcio, M.
    Mariotti, M. L.
    Fornaciari, S.
    Boggi, U.
    Scatena, F.
    TISSUE ANTIGENS, 2011, 77 (05): : 460 - 460
12345